Fadogia Agrestis vs Tongkat Ali
The famous podcast stack, pulled apart. One half has small human randomized trials; the other has rat studies that recorded organ damage alongside the testosterone rise.
Short answer
Tongkat ali rests on firmer ground than Fadogia agrestis, with human clinical data against only preclinical or minimal evidence, resting mostly on animal or lab work. Someone focused on testosterone and vitality has trial data to go on with tongkat ali; Fadogia agrestis, marketed for testosterone and libido, is still an early-research option.
Fadogia Agrestis
Raised testosterone and libido in rats — but the same rat studies found testicular and organ toxicity, there are zero human trials, and no established safe dose.
Full Fadogia Agrestis evidence reviewTongkat Ali
Eurycoma longifolia
Small RCTs of standardized extract show modest free-testosterone rises and cortisol/stress reduction — but effects are small, trials are often industry-linked, and product standardization varies enormously.
Full Tongkat Ali evidence reviewFadogia Agrestis vs Tongkat Ali: head to head
- FDA status / approved use
Fadogia Agrestis
Sold as a mass-market supplement; no human trialsTongkat Ali
Sold as a supplement; not FDA-approved for any of its marketed uses- Marketed for
Fadogia Agrestis
Testosterone, libidoTongkat Ali
Testosterone, vitality- Outcome areas
Fadogia Agrestis
Testosterone / male hormones; Sexual health / libidoTongkat Ali
Testosterone / male hormones; Mood / anxiety / stress- Evidence grade
Fadogia Agrestis
Preclinical / minimalTongkat Ali
Clinical data- How it works
Fadogia Agrestis
Proposed to boost the testes' own testosterone production; shown only in rodentsTongkat Ali
Proposed to free bound testosterone and support the body's own androgen production- Route and dosing
Fadogia Agrestis
Oral stem extract capsules; no established human doseTongkat Ali
Oral standardized root extract, about 200 mg daily- Headline human result
Fadogia Agrestis
Not establishedTongkat Ali
Share of 76 hypogonadal men with normal testosterone rose from 35.5% to 90.8% after one month at 200 mg/day (open-label)- Strongest evidence
Fadogia Agrestis
Yakubu toxicity, J Ethnopharmacol 2008. Little or no controlled human outcome data for the marketed useFadogia Agrestis evidence reviewPubMed 18023305Tongkat Ali
Talbott RCT, JISSN 2013Tongkat Ali evidence reviewPubMed 23705671- Key safety signal
Fadogia Agrestis
Testicular damage and liver and kidney toxicity in rats; no human safety dataTongkat Ali
Contamination in poorly sourced products; caution with prostate cancer or other hormone-sensitive conditions- How it is obtained
Fadogia Agrestis
Over the counter as a dietary supplementTongkat Ali
Over the counter as a dietary supplement
| Fadogia Agrestis | Tongkat Ali | |
|---|---|---|
| FDA status / approved use | Sold as a mass-market supplement; no human trials | Sold as a supplement; not FDA-approved for any of its marketed uses |
| Marketed for | Testosterone, libido | Testosterone, vitality |
| Outcome areas | Testosterone / male hormones; Sexual health / libido | Testosterone / male hormones; Mood / anxiety / stress |
| Evidence grade | Preclinical / minimal | Clinical data |
| How it works | Proposed to boost the testes' own testosterone production; shown only in rodents | Proposed to free bound testosterone and support the body's own androgen production |
| Route and dosing | Oral stem extract capsules; no established human dose | Oral standardized root extract, about 200 mg daily |
| Headline human result | Not established | Share of 76 hypogonadal men with normal testosterone rose from 35.5% to 90.8% after one month at 200 mg/day (open-label) |
| Strongest evidence | Yakubu toxicity, J Ethnopharmacol 2008. Little or no controlled human outcome data for the marketed useFadogia Agrestis evidence reviewPubMed 18023305 | Talbott RCT, JISSN 2013Tongkat Ali evidence reviewPubMed 23705671 |
| Key safety signal | Testicular damage and liver and kidney toxicity in rats; no human safety data | Contamination in poorly sourced products; caution with prostate cancer or other hormone-sensitive conditions |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
- Preclinical / minimal:
- Evidence is largely animal, in-vitro, or anecdotal. Little or no controlled human outcome data for the marketed use.
Our verdict
This is not a close call. Tongkat ali has a small set of human randomized trials of standardized water-soluble extract, with modest testosterone rises in men who started low, reduced cortisol, and reasonable tolerability at studied doses. Fadogia Agrestis is preclinical: its entire efficacy case is a dose-dependent rise in testosterone and mating behavior in rats, there are no published randomized human trials at all, and the same rat literature recorded testicular damage on 28-day dosing plus liver and kidney injury. The widely repeated 600 mg per day figure is community convention rather than a studied dose, and no dose is known to be both effective and safe in humans.
Fadogia Agrestis fits if
Realistically nobody shopping for something to take; the only honest audience is a reader following the preclinical androgen literature, and anyone with a fertility interest should treat the documented testicular-toxicity signal as disqualifying.
Tongkat Ali fits if
Someone who wants the half of the stack with actual human data, buying a standardized, third-party-tested extract and expecting a modest effect on stress and testosterone rather than a transformation.
Fadogia Agrestis vs Tongkat Ali: common questions
- Is either Fadogia agrestis or tongkat ali FDA-approved?
- No. Fadogia agrestis is sold as a mass-market supplement; no human trials. Tongkat ali is sold as a supplement; not FDA-approved for any of its marketed uses.
- Which has stronger human evidence, Fadogia agrestis or tongkat ali?
- Tongkat ali. It has human clinical data (key source: Talbott RCT, JISSN 2013), while Fadogia agrestis has only preclinical or minimal evidence (key source: Yakubu toxicity, J Ethnopharmacol 2008).
- What are the main safety concerns with Fadogia agrestis and tongkat ali?
- For Fadogia agrestis, watch for testicular damage and liver and kidney toxicity in rats; no human safety data. For tongkat ali, watch for contamination in poorly sourced products; caution with prostate cancer or other hormone-sensitive conditions.
Key studies behind each
Fadogia Agrestis
- Yakubu MT, Akanji MA, Oladiji AT. (2005). Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J Androl. PubMed 16281088
- Yakubu MT, Akanji MA, Oladiji AT. (2008). Effects of oral administration of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem on some testicular function indices of male rats. J Ethnopharmacol. PubMed 18023305
- Yakubu MT, Akanji MA, Oladiji AT. (2009). Mode of cellular toxicity of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male rat liver and kidney. Hum Exp Toxicol. PubMed 19755438
- Ogunro OB, Yakubu MT, et al. (2023). Fadogia agrestis (Schweinf. Ex Hiern) Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats. Reprod Sci. PubMed 35969364
Tongkat Ali
- Tambi MI, Imran MK, Henkel RR. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism? Andrologia. PubMed 21671978
- Henkel RR, Wang R, Bassett SH, et al. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors — a pilot study. Phytother Res. PubMed 23754792
- Talbott SM, Talbott JA, George A, Pugh M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. PubMed 23705671
- Ismail SB, Wan Mohammad WM, George A, et al. (2012). Randomized clinical trial on the use of PHYSTA freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evid Based Complement Alternat Med. PubMed 23243445
The full evidence reviews
- Fadogia Agrestis: rat-only testosterone data, and a real toxicity flag
Fadogia Agrestis is the podcast-famous testosterone herb usually stacked with Tongkat Ali. Its entire efficacy case is built on rat studies — and those same rat studies recorded testicular, liver and kidney toxicity. There are no human trials.
Updated August 2026
- Tongkat Ali: a real but modest testosterone signal, and a standardization problem
Tongkat Ali (Eurycoma longifolia, longjack) is marketed hard as natural TRT. Standardized extracts modestly raise testosterone, lower cortisol and nudge libido — but effects are small, and eurycomanone content varies wildly between products.
Updated August 2026